Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : LineaDNA vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Applied DNA Sciences Inc
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : All animals demonstrated seroconversion to producing IgG against SARS-CoV-2 Spike Protein already by day 14, and significantly enhanced responses by day 38.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Not Applicable
July 17, 2020
Lead Product(s) : LineaDNA vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Applied DNA Sciences Inc
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : COVID-eVax
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Rottapharm Biotech
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the terms of this collaboration, Rottapharm Biotech will provide Takis with operational support, and with the financial resources needed to complete Phase I/II clinical trials.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : $3.3 million
June 04, 2020
Lead Product(s) : COVID-eVax
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Rottapharm Biotech
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : DNA vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Takis Vaccines Neutralize SARS-CoV-2
Details : Researchers at National Institute of Infectious Diseases found that Takis vaccines after a single vaccination developed antibodies in mice that can block the infection of SARS-CoV-2 on human cells.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Not Applicable
May 06, 2020
Lead Product(s) : DNA vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Linear DNA vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : The vaccine is one of four PCR-produced (polymerase chain reaction vaccine) linear DNA vaccine candidates under joint development by Takis Biotech and Applied DNA.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Not Applicable
March 18, 2020
Lead Product(s) : Linear DNA vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Linear DNA vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Applied DNA Sciences Inc
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Applied DNA is expected to enter large-scale production of candidates in march; preclinical testing in animals by takis biotech anticipated to begin in calendar Q2 2020.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
March 02, 2020
Lead Product(s) : Linear DNA vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Applied DNA Sciences Inc
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Linear DNA vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Applied DNA Sciences Inc
Deal Size : Undisclosed
Deal Type : Collaboration
Applied DNA and Takis Biotech partner on coronavirus vaccine
Details : LineaRx, a subsidiary of Applied DNA, will work with Takis Biotech on preclinical development of a linear DNA vaccine based on polymerase chain reaction (PCR).
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
February 10, 2020
Lead Product(s) : Linear DNA vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Applied DNA Sciences Inc
Deal Size : Undisclosed
Deal Type : Collaboration